Patents Represented by Attorney, Agent or Law Firm Charles W. Calkins
  • Patent number: 6809817
    Abstract: The present invention relates to methods and devices for in-situ measurement of reaction components of interest during manufacturing of polycarbonate by melt polymerization. The present invention describes irradiating a molten polymer sample with UV/visible light, and generating an absorbance profile correlated to Fries products as well as uncapped phenolic groups in the sample. The methods and apparatus of the invention are suitable for monitoring of Fries products in reactions ranging in size from small scale combinatorial formats to production scale reactors. Also included in methods of the invention are univariate and multivariate analysis for prediction of linear Fries, branched Fries and uncapped phenolic end-groups in unknowns.
    Type: Grant
    Filed: August 24, 2001
    Date of Patent: October 26, 2004
    Assignee: General Electric Company
    Inventors: Radislav Alexandrovich Potyrailo, Patrick Joseph McCloskey, James Day
  • Patent number: 6793848
    Abstract: The present invention provides terbium or lutetium garnet x ray scintillators activated with a rare earth metal ion, such as cerium, and treated by annealing in a controlled atmosphere comprising a predetermined amount of oxygen for a predetermined time and temperature to reduce radiation damage that would otherwise occur when the scintillator material is exposed to high energy radiation, such as the type of radiation required to use the scintillator for medical radiographic imaging and the like. In an embodiment, a single crystal or a polycrystalline scintillator comprising the general formula (Tb1−xLuxCey)3Al5O12 (where 0<×≦0.5, and y is in the range from about 0.0005 to about 0.2, and annealed at 1400° C. to 1500° C. in a controlled atmosphere comprising 1×10−6 to 0.22 atm oxygen shows an increased resistance to radiation damage.
    Type: Grant
    Filed: December 10, 2002
    Date of Patent: September 21, 2004
    Assignee: General Electric Company
    Inventors: James Scott Vartuli, Steven Jude Ductos, Robert Joseph Lyons, Charles David Greskovich
  • Patent number: 6773890
    Abstract: It has been determined that a specific metaplastic lineage that contains immunoreactivity for a trefoil polypeptide, spasmolytic peptide, is associated with and gives rise to the vast majority of human adenocarcinomas. The identification of this Spasmolytic Polypeptide Expressing Metaplasia (SPEM) is a major factor for grading of biopsies of the stomach to assess risk for gastric cancer. It also forms the basis of a method for serological screening for those at risk for gastric cancer. In a preferred embodiment, antibodies to spasmolytic peptide (hSP) are used in immunostaining of biopsies of gastric tissue obtained by endoscopy for grading biopsies. Those patients having these cells, characterized by a morphology more typical of a type of cell present normally in the intestine and not stomach, Brunner's gland cells, are at risk of developing adenocarcinoma.
    Type: Grant
    Filed: January 29, 2002
    Date of Patent: August 10, 2004
    Assignee: Medical College of Georgia Research Institute, Inc.
    Inventors: James R. Goldenring, P. Henry Schmidt, Jeffrey R. Lee
  • Patent number: 6764368
    Abstract: The invention consists of a flat panel display device that combines the simplicity of manufacture of a TFEL display with the phosphor stimulation capabilities of an FED. A phosphor such a ZnS:Mn can act as both an EL phosphor and as a cathodoluminescent phosphor. The phosphor is deposited on a porous silicon underlayer that contains a labyrinth of fissures, voids, hillocks, and microscopically rough surfaces. At the phosphor-porous silicon interface, the labyrinthine surface possesses hundreds to thousands of electric field line compression points that can be characterized by an average field enhancement. When this underlayer is the cathode, high energy electrons are injected into the phosphor producing substantial light emission even at low applied fields. Additionally, the surrounding silicon is available to integrate drive circuitry and provide a TFT at each pixel, if needed.
    Type: Grant
    Filed: April 16, 2003
    Date of Patent: July 20, 2004
    Assignee: University of North Carolina at Charlotte
    Inventors: Mohamed Ali Hasan, Deirdre Heyde Elqaq
  • Patent number: 6733434
    Abstract: A method for beneficially restructuring ingestible substances such as sports drinks, water, neutraceuticals, pharmaceuticals, and the like and its contents for consumption by organisms. The method is also applied to topical substances such as lotions and creams. The method involves subjecting such substances for a period of time to an electromagnetic field of a specified flux density varying from 10−5 to 10−21 gauss and a specific frequency varying from 0 hertz to 300 hertz, depending on the intended subsequent use of the substance. The specific flux density and the specific frequency is empirically determined to restructure the substances such that the substances beneficially affect the organism which has the substances incorporated into the organism's metabolism.
    Type: Grant
    Filed: December 10, 2001
    Date of Patent: May 11, 2004
    Inventor: Jerry I. Jacobson
  • Patent number: 6730832
    Abstract: The present invention provides a method for producing plants with a desired phenotypic trait which comprises subjecting plants to mutagenesis, screening chimeric progeny for plants having the desired phenotypic trait, and propagating the survivors. In an embodiment, the phenotypic trait comprises an altered amino acid content. Preferably, the technique is used to generate Nicotiana tobacum plant lines having an increase in at least one amino acid. In a preferred embodiment, the invention provides improved Nicotiana tobacum plant lines producing at least 1.35 nmole of threonine per milligram of dry plant weight. These plants are useful for improving the flavor and aroma of the tobacco.
    Type: Grant
    Filed: September 10, 2001
    Date of Patent: May 4, 2004
    Inventors: Luis Mayan Dominguez, Jerry Wayne Lawson, Wennuan Liu, Michael Francis Dube
  • Patent number: 6713580
    Abstract: The present invention relates to novel templates useful for generating novel compounds and to compounds produced utilizing the templates. The templates comprise quaternary amino acids that may be linked to solid supports. These templates make possible the production of novel classes of chemical compounds through a plurality of chemical reactions. The templates are advantageous for use in drug discovery regimes.
    Type: Grant
    Filed: December 6, 2001
    Date of Patent: March 30, 2004
    Assignee: Pharmacore, Inc.
    Inventors: Michael Johnson, Keqiang Li, Elso DiFranco, Daljit S. Dhanoa
  • Patent number: 6613534
    Abstract: The invention relates to detection of MAP-2 (microtubule associated protein-2) as a marker to determine the metastatic potential of a tumor, including tumors derived from the neural crest such as melanomas, gliomas, Schwanomas, chromocytomas and small cell lung cancer. In one aspect, the invention comprises a method for determining the metastatic potential of a tumor sample, wherein decreased levels of MAP-2 expression in a test sample relative to controls indicates that the sample has increased metastatic potential as compared to the control. In another aspect, the invention comprises a method to prevent tumor progression in metastatic melanoma by increasing levels of MAP-2 protein in cells.
    Type: Grant
    Filed: March 20, 2001
    Date of Patent: September 2, 2003
    Assignee: Wake Forest University Health Sciences
    Inventors: Vijayasaradhi Setaluri, Dong Fang, Wain White
  • Patent number: 6603257
    Abstract: The invention consists of a flat panel display device that combines the simplicity of manufacture of a TFEL display with the phosphor stimulation capabilities of an FED. A phosphor such a ZnS:Mn can act as both an EL phosphor and as a cathodoluminescent phosphor. The phosphor is deposited on a porous silicon underlayer that contains a labyrinth of fissures, voids, hillocks, and microscopically rough surfaces. At the phosphor-porous silicon interface, the labyrinthine surface possesses hundreds to thousands of electric field line compression points that can be characterized by an average field enhancement. When this underlayer is the cathode, high energy electrons are injected into the phosphor producing substantial light emission even at low applied fields. Additionally, the surrounding silicon is available to integrate drive circuitry and provide a TFT at each pixel, if needed.
    Type: Grant
    Filed: May 26, 2000
    Date of Patent: August 5, 2003
    Assignee: University of North Carolina at Charlotte
    Inventors: Mohamed Ali Hasan, Deirdre Heyde Elqaq
  • Patent number: 6594922
    Abstract: The invention relates to an apparatus and methods for incorporating a medial/lateral counter foot stabilizer into shoes. In an embodiment, the medial/lateral counter foot stabilizer of the invention comprises a plantar aspect which extends the length of the sole of a foot, side walls, a metatarsal arch support, a lateral arch support, a medial arch support, and a heel cup counter. The stabilizer of the invention mimics a preferred foot shape, provides support for the metatarsal, medial, and lateral arches, and restricts pronation and supination of the foot. The stabilizer of the invention is designed to be integrated into commercial shoes during the manufacturing process as a method of providing foot support which is currently unavailable in commercial shoes.
    Type: Grant
    Filed: December 22, 2000
    Date of Patent: July 22, 2003
    Inventors: Paul A. Mansfield, Ricky T. Wyatt, John T. Wyatt, Anthony S. Wyatt
  • Patent number: 6592536
    Abstract: A method and apparatus for treating infant plagiocephaly whereby a helmet encircles the upper cranium of an infant and prevents the infant from resting its head on flattened or depressed regions of the skull. The helmet contemplates an adjustable first member which encircles the infant's upper cranium, and a second member comprising a relatively rigid protruding element that is attached to the exterior surface of the first member. The second member is positioned so that it is superincumbant to flattened or depressed regions, so that when the helmet is worn, the second member forces the infant to rest its head on a different area of the skull, thus passively relieving pressure on the depressed skull, and applying a gentle active pressure to other areas. Additionally, the method an apparatus relates to the treatment of torticollis and other abnormalities of the neck.
    Type: Grant
    Filed: January 7, 2000
    Date of Patent: July 15, 2003
    Inventor: Louis C. Argenta
  • Patent number: 6539334
    Abstract: An automated weighing station is provided which is advantageous for automatically weighing samples generally disposed in containers in an array of racks. The weighing station comprises a sample handling assembly which is operably connected to a balance, allowing a moveable sample carrier to bring samples into position beneath the balance and sample handling assembly, thereby minimizing the movement of individual samples in order to accomplish weighing. A weighing system that provides flexibility and convenience in generating and transforming a variety of data sets associated with measurements accomplished using the weighing apparatus is also provided.
    Type: Grant
    Filed: July 7, 2000
    Date of Patent: March 25, 2003
    Assignee: TransTech Pharma, Inc.
    Inventor: Reyad I. Sawafta
  • Patent number: 6469141
    Abstract: A number of cDNA clones whose products may interact with D1 receptors in vivo were identified. One of the clones, P24, was characterized further. P24 is localized in dendrites and spines of pyramidal cells in PFC. The extent of overlap between P24 expressing and D1 receptor expressing pyramidal cells appeared to be 100%. In contrast, only a limited number D1 receptor antibody labeled neurons in caudate expressed P24. P24 lowers the threshold of D1 receptor response to dopamine (DA) by an order of magnitude. Sequence similarity suggests P24 is a diverged member of the RAMP family. The P24 protein is therefore referred to as a D1 DA RAMP, calcyon. The isolated protein and nucleotide molecule encoding the protein, as well as primers for the nucleotide, are described. The protein and compounds modifying DA binding to the receptor or calcium release which is mediated by the Calcyon, are useful in research studies, drug screening, and therapeutically.
    Type: Grant
    Filed: October 8, 1999
    Date of Patent: October 22, 2002
    Assignee: Medical College of Georgia Research Institute Inc.
    Inventor: Clare Bergson
  • Patent number: 6441158
    Abstract: Disclosed are oligomers that bind Ku protein. These oligomers are useful for inhibiting activation of DNA-PK, treating certain forms of autoimmune disease, detection and purification of Ku protein, and identification of proteins that interact with Ku protein. Preferably, the oligomers are composed of nucleotides, nucleotide analogs, or a combination. Most preferably, the oligomers are composed of ribonucleotides. Also disclosed is a method of inhibiting DNA repair, a method of identifying cellular proteins that interact with Ku protein, and a method of treating autoimmune disease in patients with anti-Ku antibodies. The disclosed oligomers can have several preferred features, either alone or in combination, in addition to Ku binding. One such feature, referred to herein as inhibition activity, is inhibition of DNA-PK kinase activity. Another preferred feature, referred to herein as aptamer motifs, is the presence of one or more of the base sequences GCUUUCCCANNNAC, A(A/C)AUGA, and AACUUCGA.
    Type: Grant
    Filed: December 30, 1998
    Date of Patent: August 27, 2002
    Assignee: Medical College of Georgia Research Institute, Inc.
    Inventors: William S. Dynan, Sunghan Yoo
  • Patent number: 6430260
    Abstract: An anode target for use within an x-ray generating device including a target frame having an inner surface and an outer surface and a thermal energy transfer device. The thermal energy transfer device including a heat exchanger having an inner surface and an outer surface, at least a portion of the outer surface of the heat exchanger positioned adjacent to at least a portion of the inner surface of the target frame; a cooling medium circulating through the heat exchanger for convectively cooling the anode target; and a thermal coupling medium disposed between the inner surface of the target frame and the outer surface of the heat exchanger, the thermal coupling medium thermally coupling the target frame with the heat exchanger while permitting relative motion between the target frame and the heat exchanger.
    Type: Grant
    Filed: December 29, 2000
    Date of Patent: August 6, 2002
    Assignee: General Electric Company
    Inventor: Douglas J. Snyder
  • Patent number: 6415946
    Abstract: A head ring protects the valving assembly, or regulator, flow adjuster, and content gauge, commonly attached to a pressure vessel, such as a conventional pressurized gas cylinder. The head ring includes a base securable to the dispensing end of the pressure vessel. A plurality of posts are distributed about a perimeter of the base, each of the posts extending vertically upward from about the base to beyond the valving assembly. Each of the posts has a first end and a second end. A collar is secured to a portion of the perimeter of the base, and the collar extends vertically downward from the perimeter of the base. The collar includes a radially-extending flange at each end. A first ring horizontally extends from the posts and is secured adjacent to the first end of the posts. A second ring horizontally extends from the posts and is secured adjacent to the second end of the posts. The first ring and the second ring are radially positioned outward of the regulator, the flow adjuster and the content gauge.
    Type: Grant
    Filed: December 22, 2000
    Date of Patent: July 9, 2002
    Assignee: Aviation Mobility, LLC
    Inventors: Charles C. Carlo, Stephen H. Mauldin
  • Patent number: 6395549
    Abstract: Disclosed are an enhancer, insulator, and promoter from the HS5 region in the 5′ boundary area of the locus control region of human &bgr;-like globin genes. These transcription control sequences can be used to control expression of any desired gene of interest and can be used in any vector for this purpose. The control sequences are derived from the area in and around the U3 region of a solitary endogenous retrovirus (ERV) 9 long terminal repeat (LTR). Also disclosed are methods of expressing any gene of interest. For this purpose, the control sequences can be operably linked to the gene of interest (and operably linked to each other). The disclosed enhancers, insulators, and promoters can also be used with any other control sequences. Preferably, the control sequences are used in vectors to obtain expression of a gene of interest in a cell, including cells in animals.
    Type: Grant
    Filed: October 21, 1999
    Date of Patent: May 28, 2002
    Assignee: Medical College of Georgia Research Institute, Inc.
    Inventors: Dorothy Tuan, Qiaoming Long, Chikh Bengra
  • Patent number: 6377659
    Abstract: A thermal energy transfer device for use with an x-ray generating device or x-ray system including an anode assembly having a target, a cathode assembly positioned at a distance from the anode assembly configured to emit electrons that strike the target producing x-rays and residual energy in the form of heat, and a rotatable shaft supported by a bearing assembly. The thermal energy transfer device including a thermal gradient device positioned adjacent to and in thermal communication with one end of the shaft, the thermal gradient device operable for transferring heat away from that end of the shaft, and a fin structure positioned adjacent to and in thermal communication with the thermal gradient device, the fin structure operable for convectively cooling the thermal gradient device.
    Type: Grant
    Filed: December 29, 2000
    Date of Patent: April 23, 2002
    Assignee: GE Medical Systems Global Technology Company, LLC
    Inventors: Douglas J. Snyder, Eric Chabin
  • Patent number: 6372439
    Abstract: It has been determined that a specific metaplastie lineage that contains immunoreactivity for a trefoil polypeptide, spasmolytic peptide, is associated with and gives rise to the vast majority of human adenocarcinomas. The identification of this Spasmolytic Polypeptide Expressing Metaplasia (SPEM) is a major factor for grading of biopsies of the stomach to assess risk for gastric cancer. It also forms the basis of a method for serological screening for those at risk for gastric cancer. In a preferred embodiment, antibodies to spasmolytic peptide (hSP) are used in immunostaining of biopsies of gastric tissue obtained by endoscopy for grading biopsies Those patients having these cells, characterized by a morphology more typical of a type of cell present normally in the intestine and not stomach, Brunner's gland cells, are at risk of developing adenocarinoma.
    Type: Grant
    Filed: October 1, 1998
    Date of Patent: April 16, 2002
    Inventors: James R. Goldenring, P. Henry Schmidt, Jeffrey R. Lee
  • Patent number: 6335512
    Abstract: A welding method that enables the joining of at least two dissimilar, metallic alloys to form a weld that is free of cracks is disclosed. The method incorporates a pure (99.00% minimum by weight) nickel fill-wire, integrally assembled into the joint between the two alloyed metals to be joined. The alloys joined by this method are an iron-based, low expansivity, gamma-prime strengthened superalloy (i.e., Incoloy®) and a high carbon, powder metallurgical tool steel high in refractory metal alloying agents (i.e., CPM REX 20). Welding of the joint results in the formation of a nickel rich region within the weld, thus “inoculating” the weld against cracks. The weld joint formed by the method of the present invention can be used in the fabrication of a rotating anode bearing shaft assembly for use in an x-ray generating device.
    Type: Grant
    Filed: July 13, 1999
    Date of Patent: January 1, 2002
    Assignee: General Electric Company
    Inventors: John Warren, Paul Neitzke, Craig Higgins